Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generic Firms Get Supreme Shield From Product Liability, But Court Hints At Reg Change

This article was originally published in The Pink Sheet Daily

Executive Summary

In Pliva v. Mensing, the high court said it was impossible for generic manufacturers to comply with both state tort laws and FDA regulations requiring them to have the same labels as those for brand name counterparts.
Advertisement

Related Content

Brand-Name Drug Makers' Duty To Warn Extends After Product Sale To Another Company
Brand-Name Drug Makers' Duty To Warn Extends After Product Sale To Another Company
FDA Label Decisions On Paxil Don't Deter Verdict Against GSK In Suicide Case
FDA Label Decisions On Paxil Don't Deter Verdict Against GSK In Suicide Case
FDA Probes Generic Firms’ Liability Insurance In Context Of Labeling Rule
Generic Labeling Rule Becomes Statistical Battle As Public Meeting Looms
Public Citizen Agrees With AMA On (Drug) Liability, Petitions FDA On Generic Labeling
Generic Liability: Supreme Court Appears Divided On Whether ANDA Sponsors Must Seek Label Change When New Risks Emerge
Generic Industry Faces Uphill Battle In Preemption Case Before Supreme Court
Generic Industry Faces Uphill Battle In Preemption Case Before Supreme Court

Topics

Advertisement
UsernamePublicRestriction

Register

PS072413

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel